{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:50:56Z","timestamp":1781884256915,"version":"3.54.5"},"reference-count":30,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Differentiating recurrent disease from postsurgical changes on 18F-fluorodeoxyglucose (FDG) positron emission tomography\/computed tomography (PET\/CT) remains challenging in malignant pleural mesothelioma (MPM). This study aimed to characterize the temporal patterns of postsurgical FDG uptake and evaluate the diagnostic performance of FDG PET\/CT for detecting recurrent disease after radical surgery. Methods: We retrospectively analyzed 91 postsurgical PET\/CT scans from 45 patients with MPM who underwent extrapleural pneumonectomy (EPP; n = 29) or pleurectomy\/decortication (P\/D; n = 16). Scans were stratified into four postoperative time intervals: &lt;6 months, 6 to &lt;12 months, 12 to &lt;24 months, and \u226524 months. FDG uptake in the postsurgical bed and local recurrent lesions was quantified using maximum standardized uptake value ratios normalized to the mediastinal blood pool and liver. Recurrence was confirmed by histopathology or follow-up imaging. Results: Postsurgical FDG uptake showed a time-dependent decline, with significantly lower uptake beyond 24 months postoperatively (p &lt; 0.05). EPP patients demonstrated significantly higher postsurgical FDG uptake than P\/D patients (p &lt; 0.01). FDG PET\/CT identified occult recurrence in 23.4% of CT-negative scans. Local recurrent lesions showed significantly higher FDG uptake than postsurgical changes across all postoperative intervals (p &lt; 0.001). Conclusions: Postsurgical FDG uptake in MPM demonstrates a time-dependent decline, and surgical extent is an important determinant of background metabolic activity. Despite this variable background, FDG PET\/CT demonstrated high diagnostic accuracy for detecting recurrent disease, including CT-occult recurrences. Incorporating surgical type and postoperative interval into PET\/CT interpretation may improve diagnostic accuracy in postoperative MPM surveillance.<\/jats:p>","DOI":"10.3390\/cancers18122000","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:37:42Z","timestamp":1781879862000},"page":"2000","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FDG PET\/CT for Postoperative Surveillance in Malignant Pleural Mesothelioma: Temporal Evolution of Postsurgical Metabolic Activity and Diagnostic Performance for Recurrence Detection"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8692-1668","authenticated-orcid":false,"given":"Sun Ha","family":"Boo","sequence":"first","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Bucheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Kwon","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Eunpyeong St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Whan","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1291-0821","authenticated-orcid":false,"given":"Yeon-Sil","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-5694","authenticated-orcid":false,"given":"Sook-Hee","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie Ryung","family":"Yoo","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","article-title":"Global Incidence, Risk Factors, and Temporal Trends of Mesothelioma: A Population-Based Study","volume":"18","author":"Huang","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/CLEP.S105396","article-title":"Mesothelioma in the United States: A Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival","volume":"8","author":"Fryzek","year":"2016","journal-title":"Clin. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: The standard of care and challenges for future management","volume":"78","author":"Scherpereel","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1200\/JCO-24-02425","article-title":"Treatment of Pleural Mesothelioma: ASCO Guideline Update","volume":"43","author":"Kindler","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/0284185118776504","article-title":"Detection of loco-regional recurrence in malignant head and neck tumors: A comparison of CT, MRI, and FDG PET-CT","volume":"60","author":"Kim","year":"2019","journal-title":"Acta Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/MNM.0000000000000707","article-title":"Comparative effectiveness: 18F-FDG-PET\/CT versus CT for post-treatment follow-up of patients with lung cancer","volume":"38","author":"Sheikhbahaei","year":"2017","journal-title":"Nucl. Med. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jtho.2022.11.018","article-title":"Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group","volume":"18","author":"Katz","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"ref_10","first-page":"28s","article-title":"Early detection of cancer recurrence: 18F-FDG PET\/CT can make a difference in diagnosis and patient care","volume":"48","author":"Israel","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/bjc.2015.151","article-title":"(18)F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer","volume":"112","author":"You","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2967\/jnumed.115.155580","article-title":"Diagnostic Performance of 18F-FDG PET and PET\/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis","volume":"56","author":"Goense","year":"2015","journal-title":"J. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.semnuclmed.2021.04.002","article-title":"PET\/CT Variants and Pitfalls in Lung Cancer and Mesothelioma","volume":"51","author":"Lopci","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2214\/AJR.19.21227","article-title":"Lung Cancer Recurrence: (18)F-FDG PET\/CT in Clinical Practice","volume":"213","author":"Kandathil","year":"2019","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JTO.0b013e3181cbf465","article-title":"Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma","volume":"5","author":"Tan","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinimag.2013.06.009","article-title":"18F-FDG PET\/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up)","volume":"37","author":"Notaristefano","year":"2013","journal-title":"Clin. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00259-010-1704-x","article-title":"FDG PET\/CT patterns of treatment failure of malignant pleural mesothelioma: Relationship to histologic type, treatment algorithm, and survival","volume":"38","author":"Gerbaudo","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.18632\/oncotarget.27324","article-title":"Clinical utility of FDG-PET\/CT for post-surgery surveillance of malignant pleural mesothelioma\u2014Comparison with contrast-enhanced CT","volume":"10","author":"Kitajima","year":"2019","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","article-title":"Limitations and Pitfalls of FDG-PET\/CT in Infection and Inflammation","volume":"51","author":"Pijl","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/j.semnuclmed.2017.07.005","article-title":"FDG-PET\/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls","volume":"47","author":"Garg","year":"2017","journal-title":"Semin. Nucl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2012.04.003","article-title":"[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients","volume":"104","author":"McCurdy","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2010.04.011","article-title":"Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer","volume":"97","author":"Matsuo","year":"2010","journal-title":"Radiother. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhang, W., Liu, Z., Duan, X., Li, Y., Shen, C., Guo, Y., and Yang, J. (2023). Differentiating malignant and benign pleural effusion in patients with lung cancer: An (18)F-FDG PET\/CT retrospectively study. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1192870"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/JTO.0b013e3181c0a7ff","article-title":"Clinical value of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: An observational pilot study","volume":"4","author":"Yildirim","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A systematic review of the factors affecting accuracy of SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, C., Zhao, K., Hu, S., Huang, Y., Ma, L., Li, M., and Song, Y. (2020). The PET-Derived Tumor-to-Liver Standard Uptake Ratio (SUV (TLR)) Is Superior to Tumor SUVmax in Predicting Tumor Response and Survival After Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01630"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11547-006-0034-3","article-title":"Imaging before and after multimodal treatment for malignant pleural mesothelioma","volume":"111","author":"Fiore","year":"2006","journal-title":"Radiol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.semtcvs.2009.06.011","article-title":"Current trends in radiologic management of malignant pleural mesothelioma","volume":"21","author":"Gill","year":"2009","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13244-010-0062-3","article-title":"Causes and imaging features of false positives and false negatives on F-PET\/CT in oncologic imaging","volume":"2","author":"Long","year":"2011","journal-title":"Insights Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","article-title":"False positive and false negative FDG-PET scans in various thoracic diseases","volume":"7","author":"Chang","year":"2006","journal-title":"Korean J. Radiol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/2000\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:52:54Z","timestamp":1781880774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18122000"],"URL":"https:\/\/doi.org\/10.3390\/cancers18122000","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}